| WKN: | A1C3EQ |
| ISIN: | US69404D1081 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Pacific Biosciences of California-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 15. November 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2020 | 4,60 | 21,00 | 356,52% |
| 2 | 2013 | 1,24 | 3,71 | 199,19% |
| 3 | 2018 | 2,22 | 6,44 | 190,09% |
| 4 | 2015 | 6,32 | 12,11 | 91,61% |
| 5 | 2014 | 3,71 | 6,32 | 70,35% |
| 6 | 2023 | 7,63 | 9,20 | 20,58% |
| 7 | 2021 | 21,00 | 16,96 | -19,24% |
| 8 | 2025 | 1,77 | 1,40 | -20,90% |
| 9 | 2019 | 6,44 | 4,60 | -28,57% |
| 10 | 2012 | 2,01 | 1,24 | -38,31% |
| 11 | 2017 | 3,66 | 2,22 | -39,34% |
| 12 | 2022 | 16,96 | 7,63 | -55,01% |
| 13 | 2016 | 12,11 | 3,66 | -69,78% |
| 14 | 2024 | 9,20 | 1,77 | -80,76% |
| 15 | 2011 | 12,28 | 2,01 | -83,63% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2011 | 12,28 | 2,01 | -83,63% |
| 2 | 2024 | 9,20 | 1,77 | -80,76% |
| 3 | 2016 | 12,11 | 3,66 | -69,78% |
| 4 | 2022 | 16,96 | 7,63 | -55,01% |
| 5 | 2017 | 3,66 | 2,22 | -39,34% |
| 6 | 2012 | 2,01 | 1,24 | -38,31% |
| 7 | 2019 | 6,44 | 4,60 | -28,57% |
| 8 | 2025 | 1,77 | 1,40 | -20,90% |
| 9 | 2021 | 21,00 | 16,96 | -19,24% |
| 10 | 2023 | 7,63 | 9,20 | 20,58% |
| 11 | 2014 | 3,71 | 6,32 | 70,35% |
| 12 | 2015 | 6,32 | 12,11 | 91,61% |
| 13 | 2018 | 2,22 | 6,44 | 190,09% |
| 14 | 2013 | 1,24 | 3,71 | 199,19% |
| 15 | 2020 | 4,60 | 21,00 | 356,52% |